July 23, 2024: The Big Ten Cancer Research Consortium (Big Ten CRC) Population Science Clinical Trial Working Group has received $5,000 of a $90,000 donation to be used for collaborative research regarding rural cancer survivorship. The donation is the second given to the Big Ten CRC by the Verna Mae Jessen Trust, with the first donation of $100,000 given in 2022. Rural cancer survivors are at risk for poorer physical, social, and psychological outcomes than non-rural cancer survivors. According to Sharon Manne, PhD, (pictured left) of Rutgers Cancer Institute and... Read More
July 15, 2024: The Big Ten Cancer Research Consortium has launched new episodes for each of our podcast series: "Bridging the Gap" and "AYA Cancer in Focus." The most recent episode of “Bridging the Gap” is titled, “Patient perspective: A Black woman's personal experience regarding clinical trial treatment.” In this episode, Dr. Coral Omene from Rutgers Cancer Institute of New Jersey talks with Tina Butts, a breast cancer survivor, about her experiences as a Black female patient in a clinical trial. It is an illuminating and touching conversation about resilience, faith, and the emotional realities of life with cancer. Listen to the full episode: Read More
July 12, 2024: Mark Burkard, MD, PhD, has been named director of Holden Comprehensive Cancer Center at the University of Iowa, and will begin his new role on October 1, pending approval from the Iowa Board of Regents. He will also begin as professor in the Department of Internal Medicine in the Division of Hematology, Oncology, and Blood Marrow Transplantation in the Carver College of Medicine. Read More
May 29, 2024: A Big Ten Cancer Research Consortium (Big Ten CRC) study was published in Nature Communications on February 1, 2024. The article is titled, “Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043.” Read More
May 28, 2024: Monika Joshi, MD, MRCP, has been re-appointed as the chief scientific officer of the Big Ten Cancer Research Consortium. Read More
May 15, 2024: The Big Ten Cancer Research Consortium (Big Ten CRC) is set to participate in the American Society of Clinical Oncology® (ASCO) 2024 Annual Meeting in Chicago from May 31 to June 4. During the event, three Big Ten CRC studies will be presented, working group meetings will take place, and the Big Ten CRC will host a joint reception with Hoosier Cancer Research Network (HCRN). The Big Ten CRC will also be represented in the exhibit hall at HCRN’s booth, #37113. Read More
May 9, 2024: Raymond J. Hohl, MD, PhD, was recently named chair of the Cancer Center Directors Committee for the Big Ten Cancer Research Consortium (Big Ten CRC). In this role, Dr. Hohl will help guide strategic priorities for the Big Ten CRC as the consortium enters its second decade. Dr. Hohl has been a member of the leadership committee since the consortium’s founding in 2013 and succeeds Howard Bailey, MD, director of the University of Wisconsin Carbone Cancer Center, as the committee chair. Read More
May 7, 2024: The Big Ten Cancer Research Consortium (Big Ten CRC) recently appointed Oana Danciu, MD, as chair of the consortium’s steering committee. Dr. Danciu is associate director of clinical research at the University of Illinois Cancer Center, a breast oncologist at UI Health, and associate professor in the Division of Hematology and Oncology at the University of Illinois College of Medicine Chicago. She succeeds Vijaya Raj Bhatt, MBBS, MS, of the University of Nebraska Medical Center, as chair of the committee. Read More
May 3, 2024: The Big Ten Cancer Research Consortium (Big Ten CRC) is excited to announce the release of a new public service announcement (PSA), showcasing the importance of scientific research collaboration among the Big Ten Cancer Centers. This PSA appears on the Big Ten Network. Read More
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube